Determining the frequency of thyroid parameter measurements following rhTSH administration in a healthy, older population.

MethodsX

Department of Internal Medicine, Division of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.

Published: May 2021

Serial thyroid hormone measurement in blood following recombinant human thyroid stimulating hormone (rhTSH) administration has not been studied extensively in healthy, older populations. Current methods involve measurement of thyroid hormones mostly at 4 to 24 hours following rhTSH administration. We tailored existing protocols to measure thyroid hormones at high frequencies following 0.1mg rhTSH intramuscular (i.m.) administration to identify optimal measurement points in our healthy, older population. We designed a method with frequent blood sampling in the first 8 hours, followed by blood sampling at 24, 48 and 72 hours after rhTSH administration to measure TSH, thyroxine (T4), free T4 (fT4), triiodothyronine (T3), free T3 (fT3) and thyroglobulin (Tg). In total, we performed a series of 17 blood withdrawals in four consecutive days. Following 0.1mg rhTSH (i.m.) administration, mean thyroid parameters showed great inter-individual variation and variation over time. Mean TSH concentration showed the greatest variation in the first 8 hours following rhTSH administration. Mean T4, fT4, T3 and fT3 started showing variation from 2 hours after rhTSH administration, and were less variable than mean TSH concentration. Mean Tg was only variable at later time points, namely 24, 48 and 72 hours after rhTSH administration. In this novel method with high frequency blood sampling following 0.1mg rhTSH (i.m.) administration, we identify optimal time points for measuring thyroid gland output in a healthy, older population. Our methods and findings may be informative for further thyroid but also other hormonal axis studies.•Thyroid metabolism•Blood sampling frequency•Geriatrics and longevity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374481PMC
http://dx.doi.org/10.1016/j.mex.2021.101400DOI Listing

Publication Analysis

Top Keywords

rhtsh administration
36
hours rhtsh
20
healthy older
16
older population
12
01mg rhtsh
12
blood sampling
12
rhtsh
10
administration
10
thyroid
8
thyroid hormones
8

Similar Publications

Oldie but Goldie: The Fundamental Role of Radioiodine in the Management of Thyroid Cancer.

J Clin Med

October 2024

Endocrinology Unit, Department of Human Pathology of Adulthood and Childhood DETEV, University of Messina, 98125 Messina, Italy.

Article Synopsis
  • Recent advancements in the management of differentiated thyroid cancer (DTC) emphasize the importance of careful postoperative disease assessment to determine if iodine-131 therapy is needed and to tailor treatment goals accordingly (ablative, adjuvant, or therapeutic).
  • A comprehensive review of the literature highlights that personalized risk-based approaches to iodine-131 therapy significantly enhance early disease staging and response assessment, particularly for metastatic DTC patients.
  • Diagnostic and theragnostic uses of iodine isotopes are crucial for improving postoperative risk stratification and enabling more effective evaluation of patient responses to initial treatments.
View Article and Find Full Text PDF

Background: The high doses of radioiodine-131 (I) and, subsequently, the high radioactive burden for dog and environment warrants optimization of I therapy in dogs with thyroid carcinoma (TC).

Hypothesis/objectives: To evaluate the effect of a revised protocol with recombinant human thyroid stimulating hormone (rhTSH) on tumor radioactive iodine uptake (RAIU) in dogs with TC.

Animals: Nine client-owned dogs diagnosed with TC.

View Article and Find Full Text PDF

Background: Although standard operational procedures for pre-therapeutic dosimetry already exist for the determination of the maximum safe activity to treat differentiated thyroid cancer patients, empiric activity administration of I is still the most frequent way of treatment. In this way, the absorbed dose to the blood/bone marrow remains unknown.

Purpose: In this work, we present a strategy to estimate radiation dose to the blood in an outpatient setting.

View Article and Find Full Text PDF

(1) Background: After thyroid malignancy is ruled out, treatment options for multinodular goiter patients include surgery, levothyroxine suppressive therapy, and 131-I therapy. Surgery effectively reduces goiter size but carries risks of surgical and anesthetic complications. 131-I therapy is the only nonsurgical alternative, but its effectiveness diminishes with goiter size and depends on iodine sufficiency.

View Article and Find Full Text PDF

Diagnosis and Long-term Treatment of Suspected Congenital Hypothyroidism in a Pigeon ().

J Avian Med Surg

November 2023

Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA.

An approximately 6-month-old domestic pigeon () was presented for lethargy and an inability to perform its first molt. The pigeon was obese, had anatomical characteristics of a chick, including cere and plumage, and had a ventral coelomic soft tissue mass. Initial blood work was unremarkable.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!